27^th International Conference on Diabetes, Endocrinology and Healthcare November 27-28, 2023 Singapore City, Singapore

Benefits of Attending

• Exchange ideas and a system with diabetologists, endocrinologists, polygenic disorder analysts, specialist clinicians, polygenic disorder and medicine consultants, and scientists from over forty countries
• Discuss cooperative approaches to deliver quality activities throughout the study of polygenic disorder and medicine and therefore the drawback and treatment of polygenic disorder
• Participants will increase guides' access to associate assembly centre of individuals from consultants and leaders and might broaden perception through rating and management of systems throughout conferences
• Learn and quote vital news and challenges with huge speakers.
• With introductions, governance dialogues, panel discussions and workshops, we tend to cowl each topic from begin to complete, from large-scale world problems to methodologies to strategic problems.

Diabetes Conference | Endocrinology Congress | Healthcare Meetings | Endocrinology Meetup | Pharma Conference | Pharmaceutical Conference | Therapeutic Substance | Top Diabetes Conference | Diabetes Congress |  American Diabetes Association | Annual Clinical Conference on Diabetes

Track 1: Endocrine and Disorders
Track 2: Types of Diabetes
Track 3: Diabetes Mellitus
Track 4: Diabetes Symptoms and Complications
Track 5: Obesity and Metabolism for Diabetes
Track 6: Diabetic Retinopathy
Track 7: Diabetic Nephropathy
Track 8: Diabetic Nutrition and Diet
Track 9: Diabetes Etiology
Track 10: Diabetes: Advanced Technologies and Treatments
Track 11: Blood Glucose Dynamics and Monitoring
Track 12:  Emerging Treatments and Technologies
Track 13: Nanotechnology in Diabetes Treatment
Track 14: Prediabetes to Late-Stage Complicated Diabetes
Track 15: Clinical Care and Education
Track 16: COVID-19 and Diabetes, Post-COVID Diabetes
Track 17: Diabetes and Cardiology
Track 18: Risks and Benefits of New Therapies
Track 19: Transplantation and Artificial Pancreas
Track 20: Insulin Resistance & Insulinotherapy
Track 21: Mental Health and Diabetes
Track 22: Artificial Intelligence: The Future for Diabetes Care
Track 23: Global Diabetes Market

Global Diabetes Market 

Global Diabetes Market: is expected to grow at a CAGR of 7.6% for the forecast period of 2018-2023. The market is segmented on the basis of diabetes type, drug class, and diabetic devices. Devices for diabetics include blood glucose meters and insulin delivery devices. The blood glucose meter market will have the largest market share compared to insulin delivery systems such as syringes and pen injectors. Continuous blood glucose monitoring systems will see the fastest growth in the market.

The United States alone spends 11% of its health care expenditures on diabetes. India and China are most affected by diabetes with more than 120 million patients. The majority of diabetes patients are undiagnosed or do not have basic treatment. Some of the major manufacturers are trying to develop an artificial pancreas. Currently, CGMS devices are used with insulin pumps as a secondary prototype for the artificial pancreas. The artificial pancreas is expected to be ready for commercialization within the next decade.

Global Digital Diabetes/Management Market :

Expected to grow at a CAGR of 21.7% from 2018 to $12.03 billion by 2025. Increasing numbers of diabetes patients, increasing smartphone penetration, technological advancements in diabetes devices, and increasing funding for diabetes are the important factors in the growth of this market.

Based on The global digital diabetes management market is projected to reach $19.9 billion by 2024, up from $6.8 billion in 2019, at a CAGR of 23.8%.The growth of this market is mainly due to the increasing prevalence of diabetes, the increasing focus on the development and adoption of a digital platform for diabetes and technological progress.

Global Human Insulin Market:

Market Value Global Human Insulin is expected to register a CAGR of 8.8% over the 2018-2023 period, reflecting an increasing number of diabetes patients, a growing geriatric population, technological advancements in insulin delivery devices and increasing exposure of population for risk factors leading to diabetes.

Based on product, the human insulin market is divided into HI drugs and delivery devices. HI drugs had the largest market share in 2017, accounting for 79.5%, due to the high prevalence of diabetes, increased research and development (R&D) activities for drug discovery and development, growing market demand for HI analogues and increasing geriatric population. HI products are used in the treatment of type II diabetes, type I diabetes.

We provide the participants with different modes or ways to participate as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. The mode of participation is webinar through PowerPoint Presentation/ Video Presentation.

Keynote speaker: 45-50 minutes
Speaker (oral presentation): 25-30 minutes (only one person can present)
Speaker (workshop): 45-50 minutes (more than 1 can present)
Speaker (special session): 45-50 minutes (more than 1 can present)
Speaker (symposium): more than 45 minutes (more than 1 can present)
Delegate(only registration): will have access to all the sessions with all the benefits of registration
Poster presenter:  can present a poster and enjoy the benefits of delegate
Remote attendance:  can participate via video presentation or e-poster presentation
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes

PARTICIPATION BENEFITS: 
Attend Keynote Presentation by world’s most eminent researchers
Access to all the sessions
Get OCM certificate
Get worldwide acknowledgment to your profile and Research
Get your abstracts published with unique DOI in International Journals
Get up to 50% discounts for publishing your entire article in our open access International Journals
Get Handbooks and conference kits
Get an access to the network with eminent personalities from worldwide

Planning a trip to Singapore City, Singapore?? Attend our Meeting!!!

Issue with VISA??

To support the participants in his/her VISA application process, we issue each participant with VISA support documents. The documents are as follows,

• The official letter of INVITATION
• The official letter of the abstract acceptance
• The receipt of the payment

Points to be noted:

• Visa  Letter (the official letter of invitation) will be issued only after you have successfully registered and paid for your conference
• Visa  Letters can be issued only for the person accepted to attend the conference.

Kindly provide us with the following to provide you with VISA  LETTERS

• Your name as appears on your passport
•  Your Passport Scan Copy
•  And Abstract Acceptance letter for Presenters

One can make the payment through the following Payment Methods:

• Payment Gateway/Stripe
• Bank to Bank transfer